According to Fortune Business Insights, the global CAR-T cell therapy market was valued at USD 4.38 billion in 2023 and is projected to grow from USD 6.37 billion in 2024 to USD 16.35 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 12.5% during the forecast period. In 2023, North America dominated the market with a 68.72% share.
